Good morning. My name is Rob, and I will be your conference operator today. At this time, I would like to welcome everyone to the Unum Group Fourth Quarter 2023 Earnings Results and 2024 Outlook Conference Call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to withdraw your question, again, press the star one. Thank you. Matt Royal, Senior Vice President of Investor Relations, you may begin your conference. Wonderful. Thank you, Rob, and good morning to everyone. Welcome to Unum Group's Fourth Q uarter 2023 Earnings Call. Today, we will be discussing full year 2023 results, along with highlights from the fourth quarter. We will also use the time to discuss our outlook for 2024. Please note that today's call may include forward-looking statements. Actual results, which are subject to risk and uncertainties, may differ materially, and we are not obligated to update any of these statements. Please refer to our earnings release and our periodic filings with the SEC for a description of factors that could cause actual results to differ from expected results. Also, today's presentation may include non-GAAP financial measures, and a reconciliation to the most directly comparable GAAP measures can be found in our earnings release and the investor relations section of our website. Also, please note, references to Unum International sales and premium are presented in local currency, and core operation sales and premium results are presented on a constant currency basis. Further, discussion of adjusted operating 2023 EPS growth of 23% or $7.66 compares to 2022 historically reported EPS of $6.21. Yesterday afternoon, Unum released our earnings press release, financial supplement, and webcast presentation. All of those materials may also be found on the investor section of our website. Participating in this morning's call are Unum's President and CEO, Rick McKenney, and Steve, Chief Financial Officer, Steve Zabel. Following the remarks from Rick and Steve, additional members of management will participate in Q&A, including Mark Till, who heads our Unum International business, Tim Arnold, who heads our Colonial Life and Voluntary Benefits lines, and Chris Pyne for Group Benefits. Now, I'll turn the call over to Rick. Great. Thank you, Matt, and good morning, everyone. It's a pleasure to be here with you all today, sharing the journey of Unum throughout 2023 and where we're headed in 2024. This is the first time we've shared our outlook in conjunction with our year-end results, and I think it works well given the consistency of our actions and performance across the company. As we reflect on our progress and look ahead, I am proud to affirm our unwavering commitment to our purpose of helping the working world thrive throughout life's moments. Steadfast focus and commitment to this purpose is delivering value to customers, employees, communities, and of course, to shareholders. 2023 was a year of exceptional results across the board, with the highlight being our decades-long leadership in disability insurance shining through, and core business growth momentum building stronger with significant strides in accelerating our industry-leading digital capabilities. The capabilities we are bringing to market, such as HR Connect, Total Leave, Gather, and Help at Hand, are becoming connection points with employers and employees to bring greater customer satisfaction to the benefits experience. These advancements have been influential in attracting and retaining customers, setting us apart in a competitive landscape and ultimately driving strong top-line results, including sales of over 13% for the full year of 2023 and premium growth of over 5%. This top-line growth has returned steadily throughout the year and has us on the trajectory that we look for in our business model. As the top line has returned in 2023, our discipline with how we run the business has not wavered. Our pricing and underwriting has remained consistent to continue to deliver growth and high returns on equity. Overall, we grew EPS 23%, with most of our product lines delivering on our expectations throughout the year. I mentioned the highlight of group disability returns, but I would extend that to most of our products and continue to generate mid- to high-teens returns. An area that understandably received attention in the third quarter was our closed block. We have seen volatility in the performance of that block, and today, Steve will provide some ways to look at its overall health and performance outside of just its loss ratio. From a capital standpoint, we've executed our plans exactly how we described them coming into the year and with good results. So we exceeded expectations on value delivered to our shareholders. We raised our dividend by 10% and increased the pace of our share repurchases throughout 2023 and announced a plan to double the amount we repurchased in 2024 with our $500 million authorization. Most notably, we described a desire to fully fund the premium deficiency reserve and contribute the capital needed to support our long-term care block. Steve will discuss further, but let me emphasize, given our current assumptions and capital buffers, we have stated that we believe long-term care will not need additional capital for five years. But in reality, our belief is that will be true for much longer. Across the company, the reason that we have been able to achieve such capital results goes back to the fact that our businesses steadily generate strong cash flow, and with a year of good results, we ended the year with financial metrics that were stronger than expected, including holding company cash of $1.7 billion and RBC of 415%. Looking forward, we now expect to generate free cash flow between $1.2 billion and $1.4 billion per year. As we transition to think about 2024, the momentum from the past several years continues. We're witnessing both a market backdrop and economic environment that are highly supportive of our business, providing us with ample opportunities to grow and thrive. Our focus is to continue building on our solid foundation. We're dedicated to enhancing our core operations, maintaining our disciplined approach, and continuing to innovate in ways that resonate with our customers and the market. When we look across the company, we are hitting the ground running, and our teams are looking to build on some very strong growth rates with consolidated sales growth of high single digits and combined with good persistency, yielding premium growth in the 5%-7% range. Consistent margins, and the purchasing of shares will deliver growth of 7%-9% on top of the 23% adjusted EPS growth we delivered in 2023. Our customer-centric approach remains at the heart of our strategy. We're constantly adapting our services to meet changing market needs, ensuring we remain the preferred choice for our clients. When we met last February, we outlined our strategy and plans to build on our market-leading position. We can report that we are advancing along all fronts, and we are seeing the results. For Unum in the U.S., we are leveraging our go-to-market expertise to connect benefit solutions to HR platforms effectively, while also ensuring our leave management is a differentiator. With over 1,500 customers and counting, we've reached the notable sales milestones with our HR Connect capability, which deeply integrates with leading human capital management platforms, and we now cover over 1 million employees through Unum's Total Leave offering. In addition, we saw strong momentum in the trend of customers bundling products. Our efforts are geared towards seamless enrollment, billing, and administration via MyUnum, and establishing robust connections with select third-party platforms. These efforts to leverage technology to improve the customer experience are paying off, and in 2023, we saw record levels of employer satisfaction for customers on the MyUnum platform. In Colonial Life, the focus is on continuing to build and support our independent sales force with enhanced tools and solutions such as our proprietary industry-leading Agent Assist technology, which enables automated lead generations, CRM, and workflow, boosting agent productivity. Another key development in our arsenal is Gather, which modernizes enrollment and benefits administration and streamlines the client experience. The offering has been building, as evidenced by the annual premium associated with it, increasing from $10 million to $50 million over the course of 2023. And finally, enabling Colonial Life agents to offer Unum employer-paid products ensures they have the solution for any employer or broker. For Unum U.K., our approach has been to redefine the broker experience, setting a market-leading standard that is distinctively Unum and enhancing our relationship management model. We are dedicated to providing value-added services that drive customer engagement and loyalty, such as through Help at Hand, which offers integrated value-added services, and by delivering comprehensive management information that yields actionable insights. Moreover, we're expanding our product set to encompass a broader spectrum of risk and well-being solutions, ensuring we meet the diverse needs of our clients. And finally, in Unum Poland, we're forging ahead with a robust strategy tailored to the local market. We're scaling our direct to SME sales team and fortifying partnerships with local brokers, thereby extending our distribution network and geographical reach. All these efforts will drive growth in the number of employers and customers we serve, and in turn, will generate the growth of premiums and earnings we have articulated. Looking forward, we will also remain disciplined stewards of our capital and franchise value, and the consistency of our capital priorities remains intact. First, we ensure investments directly supporting our business. We have a clear growth strategy, continue to build out our offerings, and capitalize on our well-positioned and profitable products. Second, we will look externally to identify and pursue selective M&A that supports our internal initiatives and that are in line with this strategy. And third, we will continue to return capital to shareholders via regular dividend increases and share repurchases, as we have demonstrated through our actions in increasing both commensurate with our plans. Summing it up, our strong capital generation, $500 million of share repurchases, and no LTC contributions, will leave us in a position of greater than 400% RBC and holding company cash greater than $2 billion. For 2024, our commitment to innovation, prudent capital allocation, and shareholder returns remains steadfast. As a result, we are on track to surpass the objectives we established a year ago, and our fortified position in the market is a testament to the hard work and dedication of our teams across the globe. The strides we've made in our digital footprint, customer engagement, and capital management are the very engines of our growth. In closing, we enter 2024 with confidence in our position and ready to build off of our achievements of 2023. With our customer-first mindset, agile operations, and comprehensive financial strategies, we are not just anticipating the future, we are actively shaping it. 2024 is going to be an exciting year for Unum. I'd like to now hand it over to Steve to provide further insights into our financial strategy and outlook, as well as provide insight into the Closed Block. Thanks for your attention once again today, and Steve, I'll turn it over to you. Great. Thanks, Rick, and good morning to everyone. As Rick mentioned, we were extremely pleased with the strong finish to the year across the board. This caps two years of continued momentum building in our core operating segments. This is evident in both our sales and operating results. For the full year, sales were up 15.1% in Unum U.S., 26.7% in Unum International, and 6.2% in Colonial Life, where we saw accelerating growth each quarter, including 11.5% growth in the fourth quarter compared to the same period a year ago. Premium for our core operations increased 6.1% in the quarter compared to a year ago and finished up 5.2% for the full year, exceeding the expectation laid out last February and more consistent with our long-term expectation. Disability results were favorable across the company as well, highlighted by a group disability benefit ratio of 59.1% for the full year and 59.5% in the quarter. We do expect benefit ratios in the low 60s to continue in the near to midterm as we continue to see support for these levels in both our operations and in the market. These same trends are also supporting strong performance in our individual disability and U.K. Group Income Protection product lines. We ended the year with after-tax adjusted operating income at $1.5 billion and after-tax adjusted operating EPS of $7.66, which represents growth of 23.3% over historically reported full year 2022. The fourth quarter's results of reported after-tax adjusted operating EPS of $1.79 was impacted by two items that I would like to mention. First, the effective tax rate in the fourth quarter was elevated at 22.8%. We expect the long-term rate to be between 21.1% and 22%. Or 21.5%-22%, and vary some from period to period due to foreign tax dynamics. The variance in the fourth quarter lowered EPS by approximately $0.03. Further, Colonial Life benefits were higher by $21.7 million or $0.09 of EPS pressure due to a one-time reserve model refinement. When adjusting for these two items, which represents a better view of underlying earnings power, adjusted operating EPS in the quarter would have been $0.12 higher. The strong earnings power for GAAP was also apparent in our statutory results, with full-year after-tax operating earnings of over $1.3 billion, well ahead of our outlook last year of roughly $1 billion. These results drove significant upside to our original expectation of capital generation and, as a result, our capital position. Top-line results were also notable this year, with both sales and premium for our core operations outperforming the top end of their outlook ranges at 13.4% and 5.2% respectively. Fourth quarter's results also show that momentum isn't slowing, which we believe will set us up nicely for continued growth in 2024. These strong growth metrics are a testament to the value of our offering in the market and the success we are seeing with our key strategic initiatives that Rick discussed. Investing in these capabilities to grow our core business is a key capital priority, and as a result, the full year 2023 adjusted operating expense ratio increased to 21.7%, slightly above our expectations coming into the year. We continue to expect the expense ratio to taper off over time as the impact of our investments take further hold. For full year 2024, we expect our adjusted operating expense ratio to be slightly lower than 2023. Now, let me briefly review our 2023 results by segment. For Unum U.S., adjusted operating income increased 39.4% to $1.36, or to $1.36 billion in 2023, compared to $972.6 million in 2022. As mentioned earlier, these results were bolstered by disability performance, with group disability experiencing full-year adjusted operating earnings growth of 56.1%, and our individual disability line of business driving overall supplemental and voluntary growth of 11.7% for the year. Further, group disability ended the year with an ROE of 30.8%. The Group Life and AD&D lines experienced adjusted operating earnings growth of 94.8% as the impacts from the pandemic waned. The fourth quarter's results of $68 million were the highest since the beginning of the pandemic and were driven by favorable waiver experience, lower incidence in AD&D, with continued lower mortality results. From a growth perspective, Unum U.S. earned premium grew 5.2% to $6.6 billion due to natural growth, higher sales, and solid persistency. This result was in line with our expected premium growth rate of 4%-6%. Now, moving to Unum International, the segment continued to show strong trends in its underlying earnings power, with adjusted operating income of $158.1 million for the year, up 18% compared to the prior year. Fourth quarter U.K. results were in line with our outlook for adjusted operating earnings levels in the mid-20 million GBP range, excluding the impacts of inflation. Inflation has moderated since last year's highs, and we expect this will continue as the environment normalizes, but still benefited the U.K. this quarter by approximately 5 million GBP. We are extremely pleased with the growth levels in the U.K., highlighted by full-year sales growth of 18.6% and premium growth of 11.6%, well ahead of our original expectations of 2%-5% and 2%-4% respectively. While the U.K. business is a major driver of this segment, Poland saw significant levels of growth, increasing sales 76% and premium 24.2% for the year. Now, turning to Colonial, the segment saw growth return after a couple of years of challenged results due to the impacts of the pandemic on our sales process and agent productivity. Sales growth of 6.2% and premium growth of 1.4% for the full year does drive optimism for the further growth in 2024, and our ultimate target to return to the high single digits level of growth that this segment historically achieved. From an adjusted operating earnings perspective, full year results of $400.1 million were lower than $412.9 million a year ago, largely due to a number of unique items throughout the year, including the reserve model refinement in 4Q. That said, full year ROE was impressive at 18.1%, and we expect a high level of earnings power from this line as we enter 2024. Switching gears to the Closed Block of business and focusing on this quarter, adjusted operating earnings of $21.3 million were below our expected run rate of $30 million-$40 million. Last quarter's results of $34.2 million, as both long-term care and the remainder of our closed disability block saw sequential declines. The net premium ratio, which is indicative of the lifetime benefit ratio expectation, increased slightly to 93.5% from 93.4% in the third quarter of 2023. Under LDTI, the combination of earnings results and movements in the net premium ratio provides a more comprehensive view of long-term care claims performance compared to the previously reported interest-adjusted loss ratio, which we observed could distort underlying claims experience trends and focus solely on experience in that quarter. Overall, underlying claims experience for the block was largely in line with third quarter. Incidence remained above long-term expected levels, but has improved from the higher levels seen earlier in 2023. We continue to believe that the elevated incidence rates in 2023 were a function of inventory levels normalizing in the environment following the pandemic. We expect to see a continuation of claims catch up in 2024, albeit at a dissipating rate. Lastly, for the closed block, our alternative investment portfolio, which largely backs LTC, produced income of $21.5 million in the quarter. Since inception, our diversified alternative portfolio has produced returns in line with our long-term expectation of 8%-10%. Rounding out the segments, the corporate segment produced a loss of $36.5 million in the quarter, and we expect this level of loss to continue at slightly higher levels in 2024. So then stepping back, 2023 was an incredible year for the company, and as we turn to 2024, we see many of the same tailwinds and opportunities to win. So with all that considered, it's time to talk about our outlook for this year, and I'll start with our view of business growth and earnings power, discuss how that plays in the capital generation, and then I'll end with a little bit of a discussion on how we're executing on our strategy for long-term care. So just to orient everyone on the slides and make sure that we're following along, we're on page seven, and I want to kick off this discussion. I really reflect back to a year ago at our last outlook meeting, and in summary, we have delivered what we described last February when we were in New York City and are poised to deliver even stronger performance in 2024. We led off that discussion with a key message, and that message was that we have the ability and capacity to chart our course in 2023, and I believe that is even more true as we go into 2024. So four key messages for the outlook discussion. Number one is top line growth. It is very strong, and it's fueled by momentum and the digital capabilities that Rick mentioned. Number two, the earnings growth rates really stabilizing back to our long-term expected range after two years of very high levels, levels of growth coming out of the pandemic, and specifically some highlights that I'd like to note. First, Group Disability is back to pre-pandemic incidence rates with historically favorable levels of recovery. The second thing to note is Group Life is back to pre-pandemic levels of earnings. Third, we have a full recovery of our U.K. business model with double-digit growth rates. And lastly, momentum continuing to build in Colonial Life and the franchise that we have there. The third message for the outlook is we're at an inflection point in free cash flow, and that's due to no contributions needed for long-term care in 2024, which will allow us to return more capital to shareholders while maintaining significant capital buffers. I would end with the key message of our capital generation is really at full strength, with all capital metrics well in excess of targets. So then I'll move on to page eight, and I just want to briefly hit on some highlights for top-line expectations. We have healthy core businesses, which will deliver strong levels of growth in 2024. But I want, I want to reflect a little bit that we just came off a really good growth story in 2023. In Unum, Unum U.S., sales grew 15%, with premium growing over 5%. In international, sales grew close to 30% premium growing over 14%, and in Colonial, sales growing at 6.2%, with premium close to 1.5% growth. And then I would say to top this all off, we have maintained industry-leading margins. Our secret sauce is really to grow in a disciplined way that is sustainable and leads ultimately to earnings growth and capital generation for future growth and deployment to our shareholders. Moving on to page nine, talk a little bit more about earnings growth. So the top of the house view here is with most of our 2024 metrics, they are in or relatively in line with our long-term expectations. Long-term expectations for sales increased as we see the benefits of our investments in technology. We have strong projected earnings growth despite record levels of earnings power in 2023. It really shows the strength of the franchise. But what I'm most optimistic about is our premium growth story, as we believe the growth rates of our core businesses can surpass the growth we saw in 2023, which was still a year of recovery in some ways. Then transitioning to page ten, talk a little bit about our sources and uses of capital, and I'll orient you on the left side of the page around capital generation and really start with statutory earnings. Similar to the GAAP earnings that we just discussed, U.S. statutory earnings are also projected to be robust. But the one thing just to remind the audience of is that these earnings will be available for dividends up to the holding company in the following year or 2025. But 2023 statutory earnings of over $1.3 billion are available to us this year in 2024. I'd move next to international dividends. Given the recent performance in the U.K., they are now able to contribute their fair share of earnings through dividends to the holding company. Next, our service agreements. Those are mainly through investment management agreements, and they continue to be a strong source of free cash flow to the holding company. And so our capital generation capacity remains strong and in line with our 2023 actuals, but well above last year's outlook. So considering our interest expense expectation of $200 million, our free cash flow generation is a healthy $1.2 billion-$1.4 billion as we move past the period of capital contributions being needed for LTC. So then we arrive at capital deployment back to our shareholders, and that is also increasing significantly, with an expected increase in the dividend of 10%-15%, which we will discuss with our board later this spring and announce in the coming months. And doubling the amount of dollars spent on share repurchase, consistent with the authorization we received at the end of last year. I would note that these repurchases in 2024 may not be straight-lined throughout the year if we do see opportunities in the market to maximize this authorization throughout the year. And then our use of excess capital generated will follow our capital priorities: grow core businesses, either organic through organic investment or inorganically, shareholder dividends, and then share repurchase. So then moving on to slide 11, talk a little bit about capital targets. I'm not going to spend too much time here, as you will see consistency in our targets and our company performance. 2023 saw capital levels well in excess of our targets, and 2024 projections to be similar, providing us substantial financial flexibility. I will add that these levels of flexibility are supportive of our goal of maintaining a single A financial strength rating. We continue to make progress on that front in 2023, with our upgrade by Fitch towards the end of last year. Okay, let's move on to a few topics regarding long-term care, and I will move to page 13. So to recap our strategy, we have a focused strategy for managing the closed block, which we have progressed and continue to progress, and it is focused on three things: creating value, reducing the footprint, and increasing predictability of outcomes. In line with this strategy, we executed on a number of items we teed up as priorities with you in early 2023, and we continue to use a number of actions as we enter 2024. We have continued to mitigate interest rate risk and have done so at the current favorable interest rate environment. By repositioning cash flows and hedging, we've been able to reduce interest rate sensitivity to date by 25%, and how we measure that is with a basic DV01 measurement, which is really the dollar duration impact to surplus. So think about the sensitivity of our surplus to a 100 basis point movement in prevailing interest rates. We continue to pursue justified rate increases. Last year, we achieved over $450 million in GPV of increases and are nearing $4.5 billion of rate increase value since we started our program. Then we are using our strong capital position to create capital capacity and flexibility, providing the ability to navigate adverse events and creating confidence in our go-forward free cash flows. As committed last year, we fully recognized the premium deficiency reserve at year-end. This was an important step in protecting our future cash flows, and we will talk more on this in a moment. And finally, we remain active and will continue to look for risk transfer solutions. So then moving on to page 14, I want to spend a little bit of time talking about our interest rate risk management and really want to cover three topics here. One, discuss where we've been and accomplished over the last year. Two, what the benefit of those actions were. And three, how that has helped to mitigate any capital requirements in a downside interest rate scenario. So first of all, I'll talk about hedging and repositioning, and how that's allowed us to better match duration, improve quality, and reduce interest sensitivity. So we kicked off our more recent hedging program at the beginning of last year. Since then, we have entered into $2.6 billion of Notional Treasury forwards, and those do have an average Treasury yield of 4%. As you know, we look out and take a seven-year horizon, and it's really to try to de-risk the yields at which we can invest those cash flows as we look to the near- to medium-term. Secondly, in the third quarter of last year, we executed on a $700 million repositioning program within the LTC portfolio, and the objective of that was really to look at shorter duration assets and de-risk the new money rate that we would be able to invest those on and extend the duration to longer duration assets. We took the opportunity to do that at a nice place in the interest rate environment. We improved portfolio quality, we increased yield, and we did extend duration with no capital impact. And so the results of that is we were able to improve our duration matching measures by 25%, as I mentioned, but we also reduced the PDR in Unum America, the sensitivity to interest rate movements by 30%, and that's really demonstrated in the chart on the right side of the page. And so let me explain the table on the right quickly. It's really the same concept that we used in our Investor Day materials last year, but I just want to orient you on it. At year-end, the premium deficiency reserve that was recorded was at $1.6 billion, and then the sensitivities that we're showing here are for the 30-year Treasury yield and the impact that those would have over time with our new money rate assumption that then is incorporated into our liability discount rate. As an example, at a 4% assumption, the $1.6 billion of PDR would be reduced by $1.1 billion, assuming that the 4% assumption worked its way all the way into our three-year trailing average that we use for that construct. The dynamic really provides flexibility and appropriately, appropriately manage our LTC commitments. I think it's key two concepts here: one, we do have time to adapt as those rates work into our assumption. But I think the other thing that's very important, and we have a note on the page, is that our interest rate management actions have significantly dampened any downside risk of interest rate movements on the PDR, our balance. And I'll call out the 2% assumption here and highlight the fact that that sensitivity has been reduced by $450 million because of the actions that we have taken over the last couple of years around both hedging and our repositioning of the portfolio. All right, then I'll move on to page 15, and we wanted to give a little bit more information about both how we think about reserve sufficiency, but also some sensitivities. And so the orientation for this page is we talk about $2.8 billion of protection. What that really represents is our view of the, our current level of statutory reserves in excess of our view of the best estimate of that liability, for the liability that's within Unum America and reinsured to FairWind, plus the excess capital that we have within the FairWind entity in excess of those targets that we set. Then when you go to the table, those are really sensitivities independent of that protection, where we look at the assumptions built into our best estimate, and we look at the dollar amount impact to our best estimate, given these sensitivities. And so specifically, I would say these are liability assumption sensitivities. We addressed interest rate sensitivities on the previous page. So let me walk you through a little bit, the sensitivities themselves. So on the premium rate increase, the $1 billion really represents the full amount of value we have currently in our best estimate assumption, and so the sensitivity is to completely remove that. I, I would say from my perspective, we have had a great track record over the years to be able to deliver on achieving our premium rate targets. In fact, we've already made very good progress in the achievement of that $1 billion just since we last launched the program back in the fall. Secondly, morbidity and mortality improvement. The assumption within the best estimate reserve is $700 million, and so this sensitivity would be to fully remove that. We do believe, and we've seen over time, improvement in both morbidity and mortality in our experience, so we do believe that assumption is backed up by the data and the experience that we've seen. But we've gone ahead, just for purposes of the presentation, to fully remove that, to give an indication of the size of that assumption. And then we have three more assumptions, which are policy lapse and mortality, our claimant incidence, and our claim resolutions. We've given sensitivities here down 7.5% for the level of lapses and mortalities, an increase in claim incidence of 3%, and a decrease in claim resolutions, mostly due to mortality, of 2%. The way to think about that is those roughly approximate a one standard deviation difference over the entire life of the business for these sensitivities, and you can see the resultant impacts to our best estimate. The one thing to also remember, though, when it comes to those last three assumptions, it's critical to remember that we still do have the ability to increase our rate increase actions as a form to mitigate those adverse developments, and the impact of those additional rate increases are not reflected in these individual liability sensitivities. Then two other items to note on this page. First of all, excess capital as it emerges, which we do think will emerge in FairWind over time, it can be used to meet LTC needs across all legal entities. The point there is we, we do have the ability over time to make decisions about how to use that excess capital, that over time we believe will build in FairWind. Then the second item of note is, given our current position, along with the PDR balance dynamics described above, would be expected to meet the capital needs of the book as it does progress to peak reserves in the next ten years. So just to reiterate, under our current assumptions and in the current interest rate environment, the actions we have taken create confidence that future cash flows of the enterprise will be insulated from LTC needs. Then I'll finish off on page 16. So to close this out, let's discuss some, some key indicators of long-term health of the business, and we look at four metrics. First, the net MPR or net premium ratio. With the shift to LDTI, we believe that MPR provides a long-term outlook for block claim experience, and we will look at the movement in that metric over time. We, we gave that movement in our comments, this quarter, and we'll continue to do that over time. Secondly, closed block earnings. While we expect quarterly volatility, we would expect an annualized run rate in the $130 million-$160 million range in an environment where experience may vary quarter to quarter, assuming alternative asset yields are near longer-term ranges. The third metric would be rate increase progress, and this is a key element of our strategy, and we monitor progress against our best estimate assumptions. Recall that we increased the scope of the program with our latest assumption review, and so we'll give information over time, how we're progressing as a percentage against that best estimate assumption within the reserve liability. Then lastly, the 30-year Treasury rate, and in particular, we will look for the three-year average to remain above the 2.84% rate, which represents the current three-year average. That rate underlines our new money assumption that feeds into our liability discount rate for the premium deficiency reserve. Rates above this would signal a positive impact on the overall discount rate and related balance of the premium deficiency reserve, as is represented on page 14 of this deck. So to wrap up, we have very exciting top and bottom-line expectations for 2024. We think our financial flexibility has never been stronger, and we look forward to the year ahead. Thank you again for attending today's call, and I look forward to your questions. Now I'll turn the call back over to Rick to close. Great. Thank you, Steve. As you can see, and based on Steve's and my comments, 2024 is shaping up to be a great year for Unum. The teams are very focused on what we want to achieve this year and continued momentum in our core business and the inflection point we're seeing with capital now that our LTC block is funded, as Steve articulated, really puts us in a very good spot. So there's plenty of topics to discuss today. So with that, the team is here to field questions, and I'll turn it back to you, Rob. At this time, I would like to remind everyone, in order to ask a question, press star, then the number one on your telephone keypad. Your first question comes from the line of Joel Hurwitz from Dowling & Partners. Your line is open. Hey, good morning. First, on the core businesses, if I compare the 2024 earnings outlook relative to what you guys guided a year ago, I estimate that core business earnings expectations are over $150 million better than what would have been implied a year ago. I guess, do you see this level of core business earnings as sustainable longer term, or would you expect to have to give back some of the favorable risk results over time? Yeah, this is Steve. I can take that question, and I'll just maybe get into the math a little bit, how we're thinking about expectations going into 2024. I think the key to think about with our core businesses, we do believe that we're gonna be able to maintain the margins in our Group Disability business through the next year. And specifically, we believe that the Benefit Ratio for Group Disability will remain in that low 60% level. I would also note that we do anticipate an increase in Colonial Life earnings. I did mention we had, you know, several one-time items that did dampen the earnings of Colonial Life in 2023, and we think in 2024, that earnings will come through, you know, on a more kind of core basis. And then maybe we can hit a little bit on just the commercial environment and competitive environment and just the level of pricing in the group benefits line. Yeah, thanks, Steve. Thanks for the question, Joel. This is Chris. You know, we're really excited about where we stand, and I'd like to start with capabilities. When we're talking to new customers, you know, we're really there to help solve problems. We see, you know, many more prospects in the market who are looking to solve big problems that we address through, you know, some of the things Rick mentioned with Total Leave, HR Connect, and MyUnum. That changes the game versus, you know, a more traditional price check type environment. So from a new business perspective, we are writing strong levels of business. We expect that to continue, and we're hitting price point. That's a great day. From a renewal perspective, you know, business is favorable, and we look at it very much on a case-by-case basis. Our history of strong risk discipline from an underwriting perspective serves us really well. Again, these customers value what we bring. We're able to show up in these discussions with an opportunity to talk about long-term price stability, whether it be, you know, modest rate increase, rate pass or rate reduction. Our persistency results through the close of 2023 were quite strong as we go into 2024. Yeah, I think, Joel, you hit it. It was a step up in 2023 from an earnings perspective, but you can see from our outlook in 2024, we're looking to grow off it. So 7%-9% on top of a very strong year. You know, all those indicators that we talked about, and as Chris articulated, in particular to our group disability, but even with our Colonial Life business, are all intact, and that leads us to our, our good outlook coming off of an incredibly strong year. Okay, helpful. And then in terms of long-term care, I guess what gives you guys confidence that the experience you've been seeing is more of a catch-up versus a longer term shift in trends? And then in terms of the outlook, what's embedded in 2024 guidance for closed block earnings? Yeah, this is Steve. I can take that one. So related to incidents, I just kinda take people back a little bit on long-term care and where we've been. At the beginning of 2023, we saw very elevated incidents through the first six months. We saw that start to abate a little bit in the third quarter, albeit at still elevated levels. Going into the fourth quarter, I would say those incidence levels were pretty consistent with what we saw in the third quarter. But what we also saw during the pandemic were fairly low levels of incidents, and we could just see when we're looking at, you know, just kind of our inventory trend lines, that we were a bit below the trend lines that we would ultimately expect. And so as we approach back to those, that gives us some confidence that this was just kind of pent-up demand. The other thing that we've seen a lot of over the last six months, I would say, and maybe even a little bit before that, was a higher level of resubmission of claims, and those would be claims that had previously been submitted, but either denied or closed or recovered for other reasons. And we've seen the level of those come back in, which might indicate claims that originally had been pulled back, but now have been submitted. And so obviously, we have to continue to monitor this. We do believe that the level of incidence for a while in 2024 will probably continue at an elevated level, but we would look to monitor that then as we get into the back half of the latter year. I would say within our outlook, we still do have a level of elevated incidence built into that outlook. Okay, thank you. Thanks, Joel. Thanks, Joel. As a reminder, please limit yourself to one question and one follow-up. Your next question comes from the line of Alex Scott from Goldman Sachs. Your line is open. Hi, good morning. First question I had is just on the excess capital position, you know, at the Holdco. It, it got a lot stronger with a big dividend, it seems, in 4Q, and, and you're projecting it to get better in 2024. So just thought maybe you could give us, you know, high level, what, what are the priorities there? You've outlined share repurchases and, and, you know, we know where common dividends are. It looks like around $500 billion after that, the sort of 400 mark. So what, you know, what, what are the priorities for using that? Sure. Thanks, Alex. Just to take you back, everyone back, we've mentioned a couple of times, but the capital generation this year was very, very strong. We see it continuing as we go forward, and we ended the year in a very good capital position, as we've been building that throughout 2023. So first of all, I'll start there. Second is, you know, last year, a priority was putting more money behind long-term care and funding that level of funding up the PDR, and so that was accomplished, and I think that leaves us in a good spot as we've talked about, no more money going towards long-term care. And so then we think about the deployment opportunities we have in 2024. I'd start out first with putting it right back in our core businesses, investing in the digital capabilities we talked about. From an organic perspective, that's contemplated in our earnings, as we talk about that, as we fund internal initiatives. And we'd like to look at M&A to help - how do we continue to accelerate that growth rate, capabilities, things that surround our business, whether it's distribution, product, internal capabilities, we'll continue to look at. And when you do all of those different things, we then look at our how we'll deploy it back to our shareholders. Steve mentioned a dividend expectation, even ticked up a little bit to that 10%-15% range this year, and share repurchase, which is double where it was a year ago at $500 million. Doing all of that, we still have building capital levels, and we'll have to contemplate that, over time, what we want to do with that. These are different trend lines that we're on from a generation as well as from a deployment perspective, and so we'll be thoughtful in 2024 about how we do that. I think Steve articulated on one of his slides and mentioned, you know, we're going to be dynamic with share repurchase, so it's not something we're putting out there today. But clearly, as you said, we're in a much, much higher level of capital than we've seen over time, and we have lots of, lots of potential uses for it. Nothing particular that we have today, it will build, but we'd love to use some of that capital to deploy, to grow our business faster. And then if we don't see that opportunity to turn it back to our shareholders. Got it. Very helpful. And then I wanted to go back to some of the comments, you know, you're making on, you know, being fully funded on LTC. I guess when I look at, at the one side that's got the bullet on, you know, reserves peaking in 10 years, and there's. You know, I know you talked in the past about the natural sort of higher required capital as that reserve level builds. If we think through where interest rates are right now and sort of the $1 billion and change of PDR balance coming down, is, you know, is that enough to be fully funded just, you know, for like some finite period of time? Or when you were looking at that reserve build and then getting over the peak of it, is it really that your base case is that you're actually projecting at this point that you'll never have to fund it ever again? I mean, I just wanna understand what you mean by being fully funded, and if that's changed at all. Yeah, this is Steve. So I would separate, when we say fully funded and those statements, that's specific to, in 2023, we fully recognize the PDR and we downstream capital, okay? If I look forward though, and we look at current interest rates, and we look at our current best estimate assumptions that, you know, we do believe that that will be kind of self-contained funding for all the required capital that would be needed for the build of those reserves over the next 10 years. And then once you get beyond that, you know, those reserves will start to release, which we'll start to release some of the required capital behind that as well. So, you know, right now, with our current projections, we do take a longer term view that we're not gonna need to contribute capital to fund long-term care. Got it. Thanks. Your next question comes from the line of Suneet Kamath from Jefferies. Your line is open. Thanks. Morning, just starting with long-term care. Rick, you'd mentioned this, I think, in your opening comments about, you know, pursuing risk transfer. Obviously, the environment is dynamic. We saw a transaction late last year. Other companies have talked about bid ask coming in. So can you just give us a sense maybe where you are in that process, what the conversations are like? Has there been a change, given some of the actions that you took last year, as well as, the rate environment? Sure. Thanks, Suneet. Just a couple of comments. One, you mentioned the transaction that happened last year. It was good to see. It was a positive development, I think, after many years where we've been talking about it, but you hadn't seen anything in the market. So I'd just articulate a positive development. If you look at the transaction that was done, it's very consistent with how we've been talking about it in terms of, you know, parsing out certain risks within our block, taking on different things, finding the right counterparty. All those are things that we've been talking about what a transaction might look like. You know, for us, our message is very consistent around that. So we have the ability to work with counterparties to do that, to parse out different things. The bid-ask spread that we look at, you know, and when that closes, we'll be looking at a transaction. We're not there in terms of what we've seen out there, but we're gonna stay very active in the markets. And I think that, you know, we'll look forward to more buyers meeting sellers, but I don't think there's a change in our tone overall from a market perspective, but we're very happy to see that positive development happen in the market. So hopefully, that answered it. You know, I think our messaging will be very consistent. The only thing that's different is something has happened in the market, and that's a good thing. Got it. That, that makes sense. And then I guess as we think about your capital plans for 2024, and in particular, that slide that looked at, you know, where you expect to be at year-end 2024, I, I think all measures are, are higher than where you ended 2023. And so I guess the question is, is, is there a thought there around maybe holding back on some of the capital deployment in anticipation of some sort of transaction with respect to LTC? Is that part of the capital philosophy at the company? It's really not. When we think of a potential transaction out there. Before this year, we had plenty of capital to do it. Steve had on his slide that we have a lot of debt capacity as well, so I really would take that out of it. We're not earmarking any of those excess funds we're talking about for any particular use. We'd love to see it in terms of a good M&A transaction. If something could happen in LTC, that would be good as well, but we're not holding back any funds, you know, waiting for a transaction to happen. We've got the flexibility, the capacity to do something, even as we stand today or as we project out over the course of the year. Got it. Okay, thanks. Your next question comes from the line of Jimmy Buehler from JP Morgan. Your line is open. Hey, good morning. First, I had a question on competition in the disability market. If you look at margin for you guys, for most of your peers, they've been very strong. Just wondering why you haven't seen competition pick up or because I would have normally thought that with margins being as strong as they are, you would have seen prices come down a lot on one-month renewals, and it doesn't seem like they've moved down as much. Chris? Yeah, thanks for the question, Jimmy. You know, competition is always out there, that's for sure. But I would take you back to some of the things that we do, both from a capabilities perspective and from, you know, a claims management perspective. So again, our customers are buying a broader experience from us. I'll give you an example from MyUnum. Smaller customers who are looking for a completely integrated set of products that work really well from an administration standpoint and an enrollment standpoint. We've got the right contracts and cover, so they get really high-quality insurance, and of course, that ultimately ends up in a, you know, wonderful claim experience. Going upmarket, HR Connect is a great example where, you know, somebody's buying our products because of deep integration with, you know, leading HCM platforms like ADP's Workforce Now, Workday, and UKG. And then again, if somebody buys the Total Leave package from us, you know, they're looking for us to solve a very significant challenge with claims administration and compliance on leave management. You know, with that comes great insurance products. We've got a phenomenal claim team behind those products that do a wonderful job to make sure we pay exactly what we should pay, and do it with great care and compassion. We do a great job getting people back to work, and incidence has been favorable in the current environment, which we expect to continue. So you put that whole thing together, and, well, you know, we again go back to where I started the conversation around strong disciplined underwriting. We've got a very kind of logical way to kind of describe fair price in that environment, and it's generating strong returns. And again, this has been for a period of time, and we expect it to continue. Okay, and then just following up on, you've made a few comments on M&A, and in the past, you've done a few smaller type deals. What is it that you're looking for ideally in terms of M&A? And would you be interested in sort of larger deals as well, or should we assume a consistent approach to what you've done in the past? I think the assumption would be a consistent approach. I think we're looking at not necessarily to go far afield, but to build our positions that we have. We have opportunities to do that. There's some areas we'd like to continue to build out across the franchise, across the world on that front. But you know, when you think about other bigger transactions that do basically what we're doing today, we're going to be very, very selective, and we're going to because we think we have the opportunity to grow it organically. So hopefully that gives you a sense. We were very happy with the transaction we've done. You know, although it's been a couple of years since we've done one, but we're going to be out there in the markets, continuing to look at what makes sense for us and most importantly, what's on strategy. Okay, thanks. Your next question comes from a line of Tom Gallagher from Evercore ISI. Your line is open. Good morning. Just a few on long-term care. First is the elevated claim frequency versus your expectation. I'm solving for around 3%-4% elevated. Does that sound about right to you, or would you adjust that figure? Yeah, I, you know, probably don't want to specifically attribute the impact of claims incidents to the loss ratio. I think what I'd take you back to is just the net premium ratio and really thinking about if our actual performance is equal to the expectations built into our reserve. We should have a loss ratio of around 95%. And clearly, claims incidence has been elevated over the last several quarters, and so, you know, you've seen that MPR creep up just a little bit, and historically, you've seen higher than expected loss ratios. But, that's probably the best way to think about it, Tom. And in my comments, I did say, you know, we expect that elevation to continue some into 2024 and then, you know, dissipate over time. Thanks, Steve. But just directionally, I just want to make sure we're not talking about elevated incidents of double digits, that with what you're seeing on the claims front, it's less than that. Is that? You know, even, you know, not looking for a specific number, just want to know directionally, are we talking about a big, big change in incidents or not? Yeah. Again, going into next year, we, we don't anticipate it getting worse than what we've seen in the back half of the year. And the loss ratio that we reported during those periods of time were around, you know, 105%- 107%. So I wouldn't see it going beyond that, but, you know, we just have to see how it plays out into the future. Gotcha. And the second question, just the higher level of resubmission of claims, that you were highlighting, can you talk about maybe unpack that a little bit? What, what's happening exactly? Were there lower acceptance rates before? How does that process work? And that—this sounds like there's a little bit of an inventory on the resubmission of claims, but may, if you, if you could- Yeah. -just expand on that. Yeah, I mean, resubmissions can happen in a lot of ways. You know, we, we start to track the claim pretty early on in the submission process, and so a lot of things can happen. People can withdraw the claim, we can close the claim before it starts to pay. It may go to pay status, but it recovers very quickly, and that happens for a variety of reasons. So some of it around us accepting the claim and approving the claim, some of it may be policyholder driven, that they've changed their mind around the claim submission and come off a claim. What I would just say, though, is we have seen a higher level of that than we've historically seen, and it's something that we track, but it does create a little bit of pressure and kind of our expected incidents counts over time. Got you. And then just one final one on risk transfer. I guess one prominent feature of the MFC deal was their willingness to package some other risks along with LTC. And, you know, this again, this is just my opinion, but I believe that expanded the number of reinsurers willing to get involved. Is that, w ould you guys. I think you, the way you've talked about it in the past was LTC only deal, not really packaging other risks. But, if it allowed you to get something done, do you have the ability, and would you consider packaging other risks along with LTC? Yeah, Tom, the way I'd answer that is we've talked about how buyers can meet sellers in the process, and as we look at it, you know, we've talked to counterparties, and we've talked about it within the LTC block of how we would parse risks, think about asset management aspects of that, think about liabilities, but certainly we would be open to other things that buyers would be looking for around the franchise. So I wouldn't take that off the table, and we would have that opportunity. Great. Thanks, Rick. Your next question comes from the line of Ryan Krueger from KBW. Your line is open. Hey, thanks. Good morning. First, just a quick follow-up. Is your expectation still that in 2024, you will earn within the $130 million-$160 million range in the Closed Block, you know, maybe towards the lower end? Or can you give any more color on kind of what you assumed, for the earnings, given the higher incidence that you expect near term? Yeah, it's in that range. And the two variables would be claims incidents and really the alternative asset portfolio. You know, we've assumed that we get back to kind of longer-term yields on that portfolio, and as you know, that tends to be volatile quarter to quarter. Got it. If I could ask, I guess, one more on risk transfer. You do have the first Unum New York entity, which has, I think, a lot of older age long-term care in it and pretty conservative reserves due to the requirements in New York. Is selling the entire legal entity another option beyond, you know, separate from reinsurance, or are there other liabilities in that entity that would prevent that from occurring? Yeah, I appreciate the question, Ryan. I'm not sure I'd want to get into too much details. I think I'd just go back to my earlier comments, which is we look at the entirety of our long-term care exposure and think about, you know, how we can parse those different risks in different ways. I wouldn't want to get into legal entity or even duration-specific things until we get closer to getting something done. Okay. And then if I could maybe just sneak one last one. You talked broadly about the good environment for renewals, but could you give us any more color on just the pricing dynamic in Unum U.S.? You know, were prices—like, when you look at prices as a whole, were they relatively flat, or, you know, did you bring them down some for disability, or can you give us any more sense of what happened there? Yeah, thanks, Ryan. It's Chris. You know, we're constantly looking at different ways to kind of make sure we can grow in the most logical and profitable way possible. So you know, it's really consider it just our active underwriting and pricing approach. We're very thoughtful. We have a tremendous data. We use it all the time to be as sharp as we possibly can. We recognize trends early, and that goes into you know, what I would consider business as usual in terms of, you know, thinking about price at the case level, thinking about price, you know, in different segments where we see opportunity. So, it is a competitive world. We have growth expectations that we're really excited about. We're certain we can deliver, and we'll continue to kind of take that active approach to the process. Great. Thank you. Your next question comes from the line of Wilma, Wilma Burdis from Raymond James. Your line is open. Morning, Wilma. Next, Wilma, your line is open. Hey, hey, good morning. You guys touched on it, but I would like to confirm if $1.4 billion-$1.6 billion of annual capital generation is a good run rate beyond 2024. Is there some risk to that level if disability results normalize? Yeah, Steve, I can take that. I think that's a good planning assumption. You know, obviously, over time, we'd like the franchise to continue to grow at some rate. That would be reflected, but I think that's a good run rate. And that would anticipate for 2024, the group disability loss ratio staying in the low 60s. Our planning assumptions for capital generation and for our GAAP earnings expectations would be consistent. Okay, thank you. And then you have provided a new data point that LTC reserves are peaking in 10 years. That's sooner than I expected, especially on the group side, and it's a very good data point because it implies that we're a lot closer to knowing how reserves will develop than I initially anticipated. Could you talk about, is this an average across blocks? And if so, is there a different peak reserving timeline for the individual versus group blocks? Yeah. So it would be an aggregate view of the total reserve. And just due to the age of the blocks, as you know, you would logically think that the individual will peak sooner than the group. I would say, though, the magnitude of the reserves that we carry on those two are a bit different, just because of the relative size of or the relative richness of benefits for our group business versus our individual business. So you know, there's a lot of weighted averaging going on, but in aggregate, that's when it's going to peak. Thank you. Thanks, Wilma. Your next question comes from the line of Josh Shanker from Bank of America. Your line is open. Yeah, hi there. Sorry, one last transaction question. Apologies. But, you know, you've mentioned that in a number of years and things lined up properly, the interest rate situation is changing. Do you think there were unique circumstances on the ground that allowed a transaction to come together? Or are you currently seeing appetite that people are discussing wanting to do transactions, it's just a matter of finding the right one for you? Yeah. So I wouldn't want to spec that. I don't know what was going on, particularly on the ground, with that transaction. I can look at it just as you can from afar and say, that it's a, it's a positive development for the, for the industry and for people that are looking to do something on that front. And I would just say we have had very consistent, dialogue, very consistent, outreach, expectations, parsing. So I don't think our world has necessarily changed as a result of that. But, I think it's good for the world to see that these transactions, can happen, and, we'll continue to pursue, such a transaction. Okay. My other questions were asked. Thank you very much. Thanks, Josh. Your next question comes from the line of Mark Hughes from Truist. Your line is open. Yeah, thank you. Just, one quick one. Anything non-recurring in the recoveries? Recoveries have been very strong. We've heard from other companies that the Social Security Administration has been kind of stingy in their payouts. I know that's only a part of your recovery story, but, is that something that should be sustainable? Yeah, I, I can answer that, Mark. So I would say that if you go back really several years, we have seen a continued improvement in the performance of recoveries within our group disability block. And so what we're seeing in the more recent history is just a continuation of that. And so I, I would not view the performance in the fourth quarter as being in any way unique or non-sustainable, and that's why we feel pretty comfortable giving guidance going into next year, that we'll be able to maintain those levels of benefit ratios, that not only to the market dynamics that Chris spoke to around pricing, but also just around our operational excellence and being able to maintain that level of performance. I'll maybe throw in one more. The Colonial sales are pretty strong this quarter, up 12%. You talked about high single digits. Was there an unusual boost or easy comp this quarter? Yeah, thank you for the question. This is Tim. I would say the comps were not that easy, although they weren't extremely challenging either. But, you know, we feel good about where we landed the quarter and, frankly, the year. We think the market's growing in the 4%-6% range, and we came out at the top end of that range. We really like our strategy. We think we have the tools and technology to help our agents, brokers, and clients achieve their goals. We grew our sales leadership team by 8% last year, and, you know, on the third quarter call, I've mentioned that we are strengthening our offering in the large case commercial market, and while we still have a little bit of work to do there, we're really pleased that we saw a fourth quarter growth rate in the 500+ life market of 36%. So we're really just focused on consistency of execution and broad-based adoption of those differentiating tools and technology that we have in our portfolio. As we look forward, you know, a couple of the leading indicators we watch are new recruits and sales productivity from those new agents. In 2023 in total, recruiting was up 23%, and new agent sales were up 18%. Since all of you have been sneaking in one last question, I'll answer a question you didn't ask, but we saw a really strong growth on the Unum VB side of 10.2% last year. We're excited about the opportunities we have to cross-sell into the group block and to take advantage of those technology solutions that Chris mentioned earlier and grow that book as well. Appreciate it. Thank you. Your next question comes from a line of Mike Ward from Citi. Your line is open. Thanks, guys. Good morning. Just quickly, I was wondering if you had any kind of similar commentary on the benefit ratio, guidance, quantification type range, for AD&D or, you know, supplemental and voluntary, like, like you gave for group disability? Yeah, this is Steve. I can cover that. Maybe, you know, I'll go across all the businesses. We've talked about group disability quite a bit. I might just touch on group life. Group Life had a very good quarter in the fourth quarter, which we do not believe is sustainable. So I think a good planning assumption there would be more in that 73%-75% range. And then for really all of our other lines, including the ones that you mentioned, I would just go back to the guidance that we gave last year and where those businesses have historically performed. I think that's probably a pretty good indicator of our view of how they're going to perform going forward. Okay, thanks, Steve. And then maybe for capital return for 2024, it, you know, it sounds like there is some excess there, or, you know, capital leftover. Just curious, like, let's say, you don't, you know, come across any acquisition opportunities or bolt-ons, what have you, should we think about potential upside to that, or should we think of that as, like, a realistic, like, straight line guidance for the year? Yeah, I think, Mike, the way I'd look at it is kind of how Steve said, it would be dynamic. So we don't just set a plan and set it and forget it. We actually will be back at it all the time. So building up that excess throughout the course of the year, we're gonna be making decisions constantly about what we want to do with that, and as we get closer to those decisions, we'll certainly give the market some heads-up around that. Thanks, Rick. Your next question comes from a line of Tom Gallagher from Evercore ISI. Your line is open. Hey, thanks for the follow-up. Just a question on sales. Long-term disability sales were down 12%, group life and AD&D were up 61%. Can you comment on the mix? Should we take that to mean more price competition in long-term disability and less in group life? Is that why there was a shift or something else happening there? Yeah, thanks for the question, Tom. It's Chris. Actually, it's a good call. We saw some great opportunity in group life packaged with a lot of was packaged with current customers, so always nice to add a life insurance in that environment. We actually did have more strength in the disability sales line than it would appear. Full year sales were up 14%, and in the quarter for pure disability, pure LTD, up high single digit, 8% or so. What you don't see at the surface is that we did have soft stop-loss sales in the quarter, and that had an impact on the overall group disability sales line as we report them together. But, you know, in general, any given quarter, it can be a little bit volatile, but we did see a very good sales growth in Group LTD and Group STD, for both the quarter and the full year. Well, you know, extra good in Group Life this quarter, and, you know, the mix will move around over time. Sorry, the stop-loss, is that medical stop-loss or is that disability stop-loss? What type of product is that? Medical stop-loss. Yeah, Tom, this is a line that we launched several years ago. Just to clear, this is a line we launched several years ago opportunistically, and so you'll see that be a little bit more volatile, but I think it's a good call-out within the results. LTD was actually quite strong from a sales perspective. Gotcha. Thanks, guys. Thanks, Tom. There are no further questions at this time. Mr. Rick McKenney, I turn the call back over to you for some final closing remarks. Great. Thank you, Rob. Appreciate everybody sticking with us for a little bit more time today, as we put together both the results of 2023 and our outlook for 2024. We'll be out there working different conferences, talking to different investors. We look forward to meeting up with you here in the next several months, and appreciate you spending the time on today's call. With that, we'll end the call, Rob. Thank you. This concludes today's conference call. Thank you for your participation. You may now disconnect.